Octreotide: a therapeutic option for idiopathic intracranial hypertension.
Panagopoulos GN, Deftereos SN, Tagaris GA, Gryllia M, Kounadi T, Karamani O, Panagiotidis D, Koutiola-Pappa E, Karageorgiou CE, Piadites G.
Panagopoulos GN, et al. Among authors: deftereos sn.
Neurol Neurophysiol Neurosci. 2007 Jul 10:1.
Neurol Neurophysiol Neurosci. 2007.
PMID: 17700925
Clinical Trial.